Key Clinical Summary: Initiating Guideline-Concordant Obesity Treatment

This is a micro-learning module summary of Dr Sue Pedersen’s session which you can find here. Before participating, please read our CME and disclosure information which can be found here.

Acknowledgment: This activity is supported by an independent medical educational grant from Lilly. This online education program has been designed for healthcare professionals globally.

Introduction

Initiating evidence-based obesity care requires empathy, structure, and alignment with contemporary guidelines. This summary outlines how to open the conversation respectfully, assess obesity beyond BMI, select personalised therapy, including pharmacotherapy, and plan follow-up that supports long-term success.

Case Study: Maria

Maria, 45, presents after a prediabetes result. She has obesity, a history of mild well-controlled depression, and past negative experiences discussing weight. Her assessment: BMI 35, waist circumference 105 cm, waist–height ratio 0.6, normal BP, HbA1c 6.3%.

Opening the Conversation: Permission and Compassion

Empathy is foundational. Asking permission is the moment a patient evaluates safety. This simple step builds trust, reduces stigma, and acknowledges the patient’s lived experience. Once invited, Maria shared that her weight challenges began after childbirth and that years of criticism, at home and in healthcare, left her ashamed and reluctant to engage. This emotional burden shapes clinical engagement and must be integrated into care.

The 5 As of Obesity Management provide a structured approach to this approach:

• Ask permission: it promotes empathy and trust.
• Assess their story: explore goals, history, contributors, and classification (BMI + waist measures).
• Advise on management: discuss evidence-based options including nutrition therapy, physical activity, psychological support, medications, or surgery.
• Agree on goals: co-create a personalised, sustainable plan.
• Assist with drivers and barriers: support long-term change.

Comprehensive Assessment: Beyond BMI

Assessment is both clinical and emotional. Maria’s story reflects common chronic obesity patterns: postpartum weight gain, fatigue, limited support, and internalised bias, factors as relevant as labs.

A full obesity-centred history should cover weight trajectory, nutrition/activity habits, mental health, sleep, substance use, medications, and social context. The 4M Framework helps structure this:

• Metabolic: T2D, dyslipidaemia, hypertension, MASLD, CV disease.
• Mechanical: OSA, OA, GI reflux, plantar fasciitis, lower-limb pain.
• Mental health: mood/anxiety, screening for depression, self-esteem, internalised stigma, substance use.
• Monetary/social milieu: SES, job demands, access to healthy food, time constraints, childcare, access to care.

Maria’s profile fits clearly within this model: metabolic risk (prediabetes), mechanical contributors (central adiposity), mental health history (treated depression, internalised shame), and social pressures (family criticism, limited support).

Often, clinical trials use BMI to define obesity. However, BMI alone is insufficient, assessment should also include vital signs and anthropometric measures such as head and neck, cardiorespiratory, gastrointestinal, musculoskeletal, skin and lower limbs. Guidelines recommend integrating waist circumference, waist-to-height ratio, and waist-to-hip ratio, as these better reflect visceral adiposity and correlate with cardiometabolic risk. Maria’s waist–height ratio of 0.6 underscores her elevated metabolic risk.

Treatment Advice: The Three Pillars of Obesity Therapy

Most individuals cannot achieve or sustain meaningful weight loss through lifestyle changes alone. This reflects biology, not willpower.

Guideline-based therapy is anchored on three pillars:

• Psychological/behavioural interventions: cognitive restructuring, behavioural substitution, self-monitoring, stimulus control, problem-solving, goal setting, sleep optimisation, and stress/time management.
• Pharmacotherapy: supports weight reduction, improves comorbidities, and enhances adherence.
• Metabolic/bariatric surgery: for appropriate candidates.

Lifestyle measures remain essential but supportive. Multiple eating patterns (e.g., Mediterranean, low-GI) reduce risk but long-term adherence is challenging. Physical activity improves cardiometabolic health even without weight loss. Psychological therapy adds structured behavioural and cognitive tools to help patients manage triggers, reshape habits, and optimise sleep, time, and stress.

Why medication?

Evidence highlights two key reasons. Firstly, behaviour change alone rarely produces durable, clinically significant weight loss. Additionally, pharmacotherapy improves both weight and metabolic health while supporting ongoing behaviour change.

Pharmacotherapy: A Structured, Goal-Based Approach

The Obesity Canada Pharmacotherapy Decision Tool mirrors standard clinical reasoning:

1. Define goals: weight loss, maintenance, and/or improvement of related conditions.
2. Evaluate for monogenic/syndromic obesity in cases of early-onset severe obesity with hyperphagia.
3. Select among approved medications considering contraindications, preferences, access, cost, and targeted outcomes.
4. Initiate and titrate to optimise effect and tolerability.
5. Reassess regularly: continue long-term therapy at “best weight,” or revise contributing factors and consider adjustments/combination therapy.

Using the Decision Table in Practice

Pharmacotherapy decision tables align the main anti-obesity medications with their demonstrated benefits across cardiometabolic, mechanical, and patient-reported outcomes.

For Maria, who presents with obesity and prediabetes, GLP-based therapies and orlistat have documented benefit. Choice depends on her goals (including desired weight-loss magnitude), preferences, access, and tolerability. A decision table helps clinicians match medication profiles to individual clinical needs, grounding decisions in evidence.

Conclusion

Guideline-concordant obesity care is empathetic, personalised, and grounded in the three pillars of therapy. Assessment must extend beyond BMI, treatment must align with evidence and patient priorities, and durable success requires structured follow-up and ongoing partnership.